Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 62 (RPL31P62) is a human pseudogene corresponding to the ribosomal protein L31 gene[1][4][5][8]. Pseudogenes are stretches of DNA that resemble functional genes but are typically non-coding and do not encode functional proteins. While some pseudogenes can be transcribed and in rare cases may be translated into peptides, the majority—including RPL31P62—are generally considered non-functional and do not serve as direct therapeutic targets[2][8]. The parent gene, RPL31, is a component of the 60S ribosomal subunit, but RPL31P62 itself does not encode a functional ribosomal protein and has no known roles in disease, drug interaction, or as a biomarker[1][4][8]. There is no evidence that RPL31P62 acts as a receptor, enzyme, transporter, or other typical drug target class.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 62 (RPL31P62).